General
Preferred name
ALBENDAZOLE OXIDE
Synonyms
Albendazole sulfoxide D3 ()
Ricobendazole D3 ()
Albendazole oxide D3 ()
Ricobendazole ()
albendazole sulfoxide ()
Ricobendazole,Albendazole sulfoxide ()
Ricobendazole ()
Albendazole oxyde ()
RS 8852 ()
RS8852 ()
Rycobendazole ()
Oxido de albendazol ()
Rycoben ()
RS-8852 ()
P&D ID
PD011076
CAS
122063-18-7
54029-12-8
Tags
available
drug
Approved by
EMA
First approval
1999
Drug Status
approved
experimental
investigational
Max Phase
2.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure
P&D probe-likeness score
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION
Albendazole sulfoxide (Ricobendazole), the main active metabolite of Albendazole, exhibits anti-parasite effect against Echinococcus multilocularis Metacestodes[1].
PRICE
29
DESCRIPTION
Albendazole sulfoxide (Ricobendazole) is a metabolite of Albendazole, an anthelmintic.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Compound Sets
10
Cayman Chemical Bioactives
ChEMBL Drugs
DrugBank
DrugCentral
DrugCentral Approved Drugs
MedChem Express Bioactive Compound Library
Other bioactive compounds
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
38
Molecular Weight
281.08
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
2
Rotatable Bonds
4
Ring Count
2
Aromatic Ring Count
2
cLogP
2.26
TPSA
84.08
Fraction CSP3
0.33
Chiral centers
1.0
Largest ring
6.0
QED
0.9
Structural alerts
0
No structural alerts detected
Related compounds
Custom attributes
(extracted from source data)
Target
Parasite
tubulin polymerization
Microtubule Associated
Pathway
Anti-infection
Cytoskeletal Signaling
Microbiology/virology
MOA
Microtubule Associated inhibitor
Source data
